Dialog Box

Scientific Advisory Committee

The Maddie’s Vision Scientific Advisory Committee, comprised of Australia’s preeminent adult and paediatric haematologists/oncologists, immunologists and scientific researchers, reviews and awards funding to research projects that are criteria specific and scientific merit-based via a competitive and transparent twice-yearly granting round.



Professor David Ritchie

Chair

Professor David Ritchie is a Haematologist and Bone Marrow transplant specialist at the Royal Melbourne Hospital. He undertook his medical training and PhD in Immunology at the University of Otago before moving to Melbourne 10 years ago.

He is head of the Bone Marrow Transplant Service of Royal Melbourne Hospital. He runs two research laboratories and is involved in all aspects of research into blood and bone marrow conditions. He is the immediate past president of the Haematology Society of Australia and New Zealand and is heavily involved in training young haematologists and medical researchers.




Associate Professor Ingrid Winkler

Associate Professor Ingrid Winkler is a Senior Research Fellow of National Health and Medical Research Council (NHMRC) and head of the Stem Cells and Cancer Research Group at Mater Research - University of Queensland in Brisbane. Dr Winkler's basic research program was recognised as among 'Ten of the best research projects in Australia' by NHMRC (2013) and seeks to understand how normal and malignant Haematopoietic Stem Cells are regulated by their local microenvironments (niches) in the bone marrow.

Dr Winkler's innovative research has led to the discovery of novel strategies to protect Haematopoietic Stem Cells from acquired bone marrow failure following chemotherapy or radiation damage, as well as strategies to improve the success of leukaemia therapy by blocking access to protective niches in the bone marrow and are the basis for current clinical trials in progress.

Dr Winkler brings to this position expertise in facilitating the interactions between strong basic research, research funding success and clinical trials. Dr Winkler is also passionate about training the next generation of leaders and has initiated a highly successful mentorship program.

Dr Duncan Purtill

Dr Duncan Purtill is a clinical and laboratory haematologist at Fiona Stanley Hospital, WA. He trained at Royal Perth Hospital and Sir Charles Gairdner Hospital, and undertook fellowships at Hôpital Saint Louis, Paris, and Memorial Sloan Kettering Cancer Centre, New York.

His interests are in stem cell transplantation and cellular therapies, and in promoting the use and application of clinical trials and patient registries in haematological malignancies.

He is Director of the Blood and Marrow Transplant Program at Fiona Stanley Hospital, a member of the eviQ BMT Reference Committee, and vice-president of Australia and New Zealand Transplantation and Cellular Therapies.


Dr Pasquale Barbaro

Dr Pasquale (Paddy) Barbaro is currently a Paediatric Haematologist at the Queensland Children’s Hospital in Brisbane Australia. Pasquale undertook his Haematology training at the Children’s Hospital at Westmead and has worked as a locum Haematologist at both the Children’s Hospital at Westmead and the Royal Children’s Hospital in Melbourne before taking up the position at the Queensland Children’s Hospital. He leads the Haemoglobinopathy service at the QCH and has overseen the development of the Haemoglobinopathy unit in QLD including clinical guidelines, transition clinics and formalised surveillance protocols for children with Haemoglobinopathies. He has an interest in the diagnosis and management of Haemoglobinopathies in children and is a member of the Sickle Cell Australia working group developing national guidelines for the management of patients with Sickle Cell Disease. His other areas of work include inherited bone marrow failure syndromes and he has completed a PhD through the University of Sydney, on Telomere biology and the effect of telomere length on outcome in paediatric cancer. 

Paddy has been associated with publications on short telomere disorders, genetic diagnosis of inherited bone marrow failure syndromes as well as other non-malignant paediatric haematology.

Professor Kanta Subbarao

Professor Kanta Subbarao is the Director of the WHO Collaborating Centre for Reference and Research on Influenza and Professor, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity.

She is a virologist and a physician with specialty training in paediatrics and paediatric infectious diseases. Prior to her arrival in Melbourne, she was a senior scientist at the US National Institutes of Health and Centers for Disease Control and Prevention.

Over the years, Professor Subbarao’ s research has focused on newly emerging viral diseases of global importance including seasonal and pandemic influenza, SARS, MERS and now, SARS-CoV-2. Her current research efforts are directed at understanding the biology and immune responses to influenza viruses and vaccines and SARS-CoV-2.

She is an internationally recognised leader in the field of emerging respiratory viruses. In response to the COVID-19 pandemic, she has been invited to serve on several international panels on animal models and vaccines.


Dr Andrea Henden

Dr Andrea Henden is a clinical Haematologist and early career research scientist. She completed her clinical and laboratory Haematology fellowships in 2013 and is employed as a senior staff specialist in Haematology and Bone Marrow Transplant at the Royal Brisbane and Women's Hospital in Queensland. 

She gained her PhD in 2019, examining transplantation immunology and the role of immune signalling molecules in post-transplant outcomes under the supervision of Professor Geoff Hill at QIMR Berghofer Medical Research Institute. 

Dr Henden now works in the Translational Cancer Immunotherapy Laboratory at QIMR Berghofer and her current research focuses on genomic and immune influences on bone marrow transplantation and cellular therapy outcomes.

Associate Professor Zoe McQuilten

A/Prof Zoe McQuilten is a consultant haematologist at Monash Health and a NHMRC Emerging Leader Fellow at Monash University. She is the Deputy-Director of the Transfusion Research Unit at Monash University and a senior research fellow with the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC).

Her other appointments include Chair of the Supportive Care Group for the Australasian Leukaemia and Lymphoma Group.

A/Prof McQuilten’s research program is focused on evaluating interventions to improve supportive care and transfusion practice in areas of major blood use, including Aplastic Anaemia, haematological malignancies, critical care and trauma.

Associate Professor Tony Cesare

Tony Cesare is an Australian Research Council Future Fellow, Associate Professor in the Faculty of Medicine and Health at the University of Sydney, and head of the Genome Integrity Unit at the Children’s Medical Research Institute (CMRI). He trained as a PhD student at the University of North Carolina at Chapel Hill, as a USA National Science Foundation International Research Fellow at CMRI, and as an NIH Post-doctoral Fellow at the Salk Institute for Biological Studies (La Jolla, California).

A/Prof Cesare directs a cell and molecular biology research program that investigates how healthy human cells maintain genome stability and the consequences when these processes fail. His research team is known for their work in telomere biology and chromosome end protection. They also explore how cells respond to treats that arise during DNA replication and the mechanisms of cell death induced by genomic instability and cancer therapy.

Dr Victoria Ling

Dr Victoria Ling is a clinical and laboratory Haematologist at the Princess Alexandra Hospital and a post-doctoral research scientist at QIMR Berghofer Medical Research Institute in Brisbane. She is an honorary senior lecturer at the University of Queensland. She completed her haematology training through the Alfred Hospital in Melbourne (2015), prior to gaining her PhD at QIMR Berghofer and University of Queensland in Brisbane (2019).

She has ongoing translational research interests in better understanding the clinical and genetic contributors to therapy response, including the impact of clonal evolution leading to disease and through treatment, and how to circumvent therapeutic failure in haematological malignancies. Specifically, her PhD and post-doctoral research focusses on investigating genetic mechanisms causing chemoresistance in acute myeloid leukaemia and targeting these pathways with rationally designed, novel therapeutic combinations to enhance chemotherapy response.


Ground-breaking research: Inside the laboratory at St Vincent's Institute


Donate